Breast Implants Market

Report Overview

The global breast implants market was pegged at US$ 2.76 billion in 2020 and is expected to witness a CAGR of 10.7% during the forecast period.

Market Fundamentals

A breast implant is a medical prosthesis that is placed inside the breast to augment, reconstruct, or create the physical form of the breast. In reconstructive surgery, implants can be placed to restore a natural-looking breast following a mastectomy to replace breast tissue that has been removed due to cancer or trauma and to correct congenital defects & deformities of the chest wall. On the other hand, in augmentation surgery also called breast enlargement, mammoplasty, or boob-job, the appearance of the breast is enlarged. Furthermore, implants are also used in revision surgeries, to correct or improve the result of an original breast implant surgery.

[2344]

Market Dynamics

The global breast implants market is mainly driven by the rising prevalence of breast cancer, the growing number of breast implant procedures, and technological advancements in breast implants & procedures. Breast cancer is the most common cancer in women in the United States, except for skin cancers. It accounts for around 30% of the total female cancer each year. Mastectomy is commonly adopted as a way to treat or prevent the spread of breast cancer, which removes all breast tissue from a breast. After mastectomy, breast implantation is the most common option used for breast reconstruction. Furthermore, the increasing demand for cosmetic surgical procedures is also likely to play a pivotal role in contributing to the growth of the market. 

However, complications associated with the implants are likely to restrain the market growth to a certain extent. Complications related to breast implants include infection, chronic breast pain, rupturing or leaking of the implant, necrosis, and breast or nipple numbness. Moreover, among the patients who had undergone reconstruction surgery, around 45% of patients with silicone gel implants and around 20% with saline implants underwent at least one additional operation within 3 years. This increases the overall cost of the treatments and their associated complications which are also expected to limit their adoption to a certain extent.

Market Ecosystem

The global breast implants market has been analyzed from three perspectives: Type, Application, End User, and Region. 

Breast Implants Market by Type

Based on type, the breast implants market has been segmented into silicone implants and saline implants. The silicone implant segment dominated the market with the largest share in 2020. According to the American Society of Plastic Surgeons (ASPS) annual plastic surgery statistics report (2018), 88% of total 2018 breast implants were silicone, whereas 12% were saline implants. The growth of the segment can be attributed to the benefits of silicone implants over saline implants such as their more natural look, lighter weight, and their availability in different sizes & shapes. It is the most preferred among women seeking breast augmentation procedures as compared to saline breast implants, owing to its more firm and appealing appearance.

[7688]

Breast Implants Market by Application

Based on application, the breast implants market has been segmented into breast reconstruction and breast augmentation. The breast reconstruction segment is anticipated to be the fastest-growing application segment during the forecast period. The growth of the segment can be attributed to the rising incidence of breast cancer, growing public and private initiatives, and favorable reimbursement policies.

Breast Implants Market by End User

Based on end user, the breast implants market has been segmented into hospitals, cosmetology clinics, and others (ambulatory care centers, etc.). The cosmetology clinics segment is anticipated to be the fastest-growing end user segment during the forecast period owing to the growing number of cosmetology clinics globally coupled with increasing breast augmentation procedures in these clinics.

Breast Implants Market by Region

Based on region, the global breast implants market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the breast implants market in 2020, followed by the Asia Pacific. The large share of North America in the global market can largely be attributed to the developed healthcare infrastructure, greater adoption of advanced implant technologies, the rising demand for breast augmentation, and the growing prevalence of breast cancer. According to the American Society of Plastic Surgeons (ASPS), breast augmentation and breast reduction were among the top five procedures performed on teens.

Competitive Landscape

Some of the prominent players operating in the breast implants market are 

• AbbVie
• Polytech Health & Aesthetics GmbH
• Johnson & Johnson Services, Inc.
• Sebbin
• Sientra, Inc.
• GC Aesthetics
• Silimed
• Establishment Labs S.A.
• Ideal Implant Incorporated
• Laboratoires Arion, among others

Strategic Developments

• In April 2021, Sientra, Inc. announced a strategic partnership with Butterfly Network, Inc. This partnership was aimed to strengthen Sientra's strong safety profile and to improve diagnostic surveillance of breast implant patients
• In February 2021, PatientFi (financing company) entered into a partnership with Allergan Aesthetics to provide Natrelle breast implant financing options to patients. The partnership was aimed to provide patient-friendly financing to make breast augmentation more affordable for patients and accessible to plastic surgery practices
• In June 2020, Allergan Aesthetics, an AbbVie company, initiated a digital campaign to improve device tracking breast implant patients who have had BIOCELL breast implants and/or tissue expanders. This would help identify patients who are at risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)
• In November 2019, BellaSeno announced the signing of a long-term agreement for the use of specialty chemical company Evonik's RESOMER bioresorbable polymer to discover a novel breast implant technology
• In November 2019, Sientra, Inc. announced the acquisition of the FDA-approved silicone breast implant manufacturing operation in Franklin, Wisconsin, from Lubrizol Life Science

Frequently Asked Questions About This Report